← Leaderboards
Ann Jorns Melvin
University Of Washington
$2,384,240
Attributed
$4,768,479
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2020–23$2M$1.5M$1M$500K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$4,768,479 · 2
By mechanism
R33$2,684,650 · 1
R61$2,083,829 · 1
Top collaborators
- Rodney J.Y. Ho4 shared
Most similar at University Of Washington
Same institution · by research overlap
- Jashvant D Unadkat$14,909,800
- Rodney J.y. Ho$31,444,678
- Qingcheng Mao$5,491,198
- Bhagwat Prasad$6,430,223
- Allan Edward Rettie$24,434,501
Others in their field
Other Emerging Leaders on “Ensure”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Lisa Garcia Bedolla · University Of California-Berkeley$175,927,128
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$142,551,806
Research focus
EnsureAdherenceDoseDrug TargetingAnti-Retroviral AgentsAntiretroviral TherapyAdolescentAnti-Viral EfficacyDosage FormsDrug KineticsBloodCellsChildChildhoodClinical DevelopmentClinical PathsCombatCombination Drug TherapyAdultCommunicationDrug CombinationsDeglutitionDevelopment PlansEvaluation
Grant awards (4)
NextGen Long-acting and targeted combination ART for Children with HIV$1,424,502
R33 · FY2023 · AI
NextGen Long-acting and targeted combination ART for Children with HIV$1,260,148
R33 · FY2022 · AI
NextGen Long-acting and targeted combination ART for Children with HIV$1,056,967
R61 · FY2021 · AI
NextGen Long-acting and targeted combination ART for Children with HIV$1,026,862
R61 · FY2020 · AI